Autoimmune diseases and COPD risk: A Mendelian randomization study

被引:0
|
作者
Ma, Xinlai [1 ]
Sun, Yuxiao [1 ]
Mou, Hongyu [1 ]
Zhang, Wei [2 ]
机构
[1] Shandong Univ Tradit Chinese Med, Clin Med Coll 1, Jinan, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Dept Pulm & Crit Care Med, Jinan, Peoples R China
关键词
Autoimmune diseases; COPD; Mendelian randomization; OBSTRUCTIVE PULMONARY-DISEASE; MULTIPLE GENETIC-VARIANTS; EPIDEMIOLOGY; PATHOGENESIS;
D O I
10.1016/j.intimp.2024.112791
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Studies in epidemiology have indicated a link between chronic obstructive pulmonary disease (COPD) and various autoimmune conditions.This study aimed to investigate the potential causal link between nine autoimmune diseases with a genetic basis and COPD using a two-sample Mendelian randomization (MR) analysis. Method: To test the impact of susceptibility to immune-related outcomes on genetic prediction of COPD risk, we used pooled statistics from the largest genome-wide association study (GWAS) in Europe in a two-sample MR setting.Genetic data for type 1 diabetes, hypothyroidism, systemic lupus erythematosus, and primary biliary cirrhosis were obtained from the European Bioinformatics Institute (EBI), while data for multiple sclerosis and primary sclerosing cholangitis were extracted from the Integrative Epidemiology Unit (IEU) database. Additionally, genetic data for ulcerative colitis, rheumatoid arthritis, and celiac disease were also collected.These nine autoimmune diseases and the COPD cohort from the UK Biobank (1605 cases and 461,328 controls) were analyzed separately as exposure and outcome.Our primary method for the initial screening was inverse variance weighting (IVW).The MR-Egger regression test assessed multivariate validity, while the Cochran's Q test examined heterogeneity.To ensure the reliability of the findings, a leave-one-out analysis was conducted. Result: IVW discovered proof of type 1 diabetes (OR = 1.0003; 95 % CI = 1.0000-1.0005; P = 0.046), hypothyroidism (OR = 1.0004; 95 % CI = 1.0001-1.0008; P = 0.0263), celiac disease (OR = 1.0002; 95 % CI = 1.0000-1.0004; P = 0.0168) and systemic lupus erythematosus (OR = 1.0002; 95 % CI = 1.0000-1.0004; P = 0.049) were significantly linked to the heightened risk of COPD with no signs of variation or pleiotropy.Even after accounting for potential confounding factors like smoking, the correlation remained robust.Additionally, our research found that the IVW method did not indicate any causal link between COPD and multiple sclerosis, ulcerative colitis, rheumatoid arthritis, primary biliary cirrhosis, or primary sclerosing cholangitis (all P >0.05). Conclusion: This research discovered that individuals with type 1 diabetes, hypothyroidism, celiac disease, and systemic lupus erythematosus have a higher likelihood of developing COPD.Additionally, this research revealed no connection between COPD and multiple sclerosis, ulcerative colitis, rheumatoid arthritis, primary biliary cirrhosis, or primary sclerosing cholangitis.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Does autoimmune diseases increase the risk of frailty? A Mendelian randomization study
    Zhou, Jinlei
    Zhang, Yuan
    Ni, Ting
    Li, Yanlei
    Shao, Haiyu
    Wang, Fei
    Xu, Sen
    Huang, Yazeng
    Zhang, Jun
    Zhao, Tingxiao
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [2] Autoimmune diseases and risk of gestational diabetes mellitus: a Mendelian randomization study
    Xia Zhang
    Xiuyan Wu
    Lihong Chen
    Lidan He
    [J]. Acta Diabetologica, 2024, 61 : 161 - 168
  • [3] Autoimmune diseases and risk of gestational diabetes mellitus: a Mendelian randomization study
    Zhang, Xia
    Wu, Xiuyan
    Chen, Lihong
    He, Lidan
    [J]. ACTA DIABETOLOGICA, 2024, 61 (02) : 161 - 168
  • [4] Multisite chronic pain and the risk of autoimmune diseases: A Mendelian randomization study
    Tang, Yidan
    Liu, Weizhi
    Kong, Weishuang
    Zhang, Shuangyi
    Zhu, Tao
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [5] COVID-19 vaccination and the risk of autoimmune diseases: a Mendelian randomization study
    Shan, Jiayi
    Hu, Xiaoyun
    Chen, Tianzhu
    Wang, Yuyang
    Huang, Baoyi
    Xin, Yijun
    Xu, Hua
    [J]. FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [6] Graves' disease and the risk of five autoimmune diseases: A Mendelian randomization and colocalization study
    Su, Tao
    Gan, Ying
    Ma, Shulin
    Wu, Hongzhen
    Lu, Shilin
    Zhi, Min
    Wang, Bao
    Lu, Yi
    Yao, Jiayin
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (05)
  • [7] The causal effect of obesity on the risk of 15 autoimmune diseases: a Mendelian randomization study
    Li, Xunliang
    Zhu, Jie
    Zhao, Wenman
    Zhu, Yuyu
    Zhu, Li
    Shi, Rui
    Wang, Zhijuan
    Pan, Haifeng
    Wang, Deguang
    [J]. OBESITY FACTS, 2023, 16 (06) : 598 - 605
  • [8] Autoimmune Diseases and Lung Cancer: A Mendelian Randomization Study
    Zhou, Huaqiang
    Liu, Jiaqing
    Zhang, Yaxiong
    Huang, Yan
    Zhang, Li
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (08) : E161 - E163
  • [9] Autoimmune diseases and the risk of bladder cancer: A Mendelian randomization analysis
    Li, Jun
    Cheng, Cui
    Zhang, Jiajun
    [J]. JOURNAL OF AUTOIMMUNITY, 2024, 146
  • [10] Mendelian Randomization Analysis of Circulating Cytokines and Risk of Autoimmune Neuroinflammatory Diseases
    Tao, Sha-Sha
    Cao, Fan
    Zhang, Ruo-Di
    Xu, Shu-Zhen
    Li, Xiao-Xiao
    Tang, Jian
    Yang, Xiao-Ke
    Pan, Hai-Feng
    [J]. IMMUNOTARGETS AND THERAPY, 2024, 13 : 273 - 286